电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

BDS-1

BR, InhA
产品编号 ABIN2566174
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for BDS-1 (ABIN2566174)

应用范围

Blocking Reagent (BR), Inhibition Assay (InhA)
  • 原理

    BDS-I is a selective blocker of Kv3.4 channel

    序列

    AA sequence: Ala-Ala-Pro-Cys4-Phe-Cys6-Ser-Gly-Lys-Pro -Gly-Arg-Gly-Asp-Leu-Trp-Ile-Leu-Arg-Gly- Thr-Cys22-Pro-Gly-Gly-Tyr-Gly-Tyr-Thr-Ser- Asn-Cys32-Tyr-Lys-Trp-Pro-Asn-Ile-Cys39->Cys40 -Tyr-Pro-His-OH Disulfide bonds: Cys4-Cys39, Cys6-Cys32, Cys22-Cys40

    产品特性

    BDS-1 is a 43 amino acid peptide which was originally isolated from the venom of the sea anemona Anemonia Viridis. BDS-1 was originally described as a highly selective blocker of the rapidly inactivating voltage-gated potassium channel Kv3.4/ KCNC4, a potential therapeutic target for major CNS disorders (Alzheimer and Parkinson diseases). The toxin acts as gating modifiers, mainly by shifting the voltage-dependence of activation. Channel block occurs with high affinity (IC50 of 43 nM) and is rapid and reversible. BDS-1 also blocks the Kv3.1 and Kv3.2 channels albeit with a lower affinity (>200 nM). Finally, in a more recent study, it was demonstrated that BDS-1 is a selective gating activator of the Nav1.7 channel subtype, an important target for pain management. On the human isoform, modulation is witnessed by a drastic slowing of channel inactivation which occurs with an IC50 of 3 nM.

    Formula

    C210H297N57O56S6
  • 限制

    仅限研究用
  • 状态

    Solid

    储存条件

    -20 °C
  • 分子量

    4708.37 Da
You are here: